• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

QuantiFERON®-TB Gold test conversion in a psoriatic patient with pleural tuberculosis one year after adalimumab treatment.

作者信息

Huang Tzu-Hung, Wei Yu-Ching, Lan Cheng-Che E

机构信息

Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Department of Pathology, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.

出版信息

Kaohsiung J Med Sci. 2018 Mar;34(3):179-180. doi: 10.1016/j.kjms.2017.11.001. Epub 2017 Dec 6.

DOI:10.1016/j.kjms.2017.11.001
PMID:29475466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11915604/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1a/11915604/ea612fe273fa/KJM2-34-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1a/11915604/ea612fe273fa/KJM2-34-179-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b1a/11915604/ea612fe273fa/KJM2-34-179-g001.jpg

相似文献

1
QuantiFERON®-TB Gold test conversion in a psoriatic patient with pleural tuberculosis one year after adalimumab treatment.一名银屑病患者在接受阿达木单抗治疗一年后发生胸膜结核，其QuantiFERON®-TB Gold检测结果出现转换。
Kaohsiung J Med Sci. 2018 Mar;34(3):179-180. doi: 10.1016/j.kjms.2017.11.001. Epub 2017 Dec 6.
2
Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.与异烟肼、利福平联合治疗相比，6 个月异烟肼和利福平治疗胸腔结核的长期疗效。
Eur J Clin Microbiol Infect Dis. 2019 Nov;38(11):2121-2126. doi: 10.1007/s10096-019-03651-7. Epub 2019 Aug 3.
3
Down-titration of Adalimumab and Etanercept in Psoriatic Patients: A Multicentre Observational Study.银屑病患者中阿达木单抗和依那西普的减量治疗：一项多中心观察性研究。
Acta Derm Venereol. 2016 Feb;96(2):251-2. doi: 10.2340/00015555-2209.
4
[Treatment of pleural and pulmonary tuberculosis by drug combinations including rifampicin. Early results].[采用含利福平的联合药物治疗胸膜和肺结核。早期结果]
Rev Clin Esp. 1972 Jul 15;126(1):59-64.
5
Comprehensive long-term safety of adalimumab from 18 clinical trials in adult patients with moderate-to-severe plaque psoriasis.阿达木单抗在 18 项成人中重度斑块型银屑病临床试验中的综合长期安全性。
Br J Dermatol. 2019 Jan;180(1):76-85. doi: 10.1111/bjd.17084. Epub 2018 Oct 10.
6
A case of isoniazid-induced liver injury diagnosed by use of the DLST, and successful reintroduction of isoniazid for pleural tuberculosis.一例异烟肼肝损伤病例，使用 DLST 诊断，并成功重新引入异烟肼治疗胸腔结核。
J Infect Chemother. 2011 Aug;17(4):530-3. doi: 10.1007/s10156-010-0189-7. Epub 2010 Dec 25.
7
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation.阿达木单抗治疗儿童和青少年重度斑块状银屑病：安全性评价。
Expert Opin Drug Saf. 2020 Apr;19(4):433-438. doi: 10.1080/14740338.2020.1752659. Epub 2020 Apr 26.
8
Unusual radiographic abnormalities observed during treatment of tuberculous pleural effusion.结核性胸腔积液治疗期间观察到的异常影像学表现。
Tubercle. 1974 Dec;55(4):261-7. doi: 10.1016/0041-3879(74)90035-x.
9
Management of long-term therapy with biological drugs in psoriatic patients with latent tuberculosis infection in real life setting.在真实生活环境中，对潜伏性结核感染的银屑病患者进行生物药物长期治疗的管理。
Dermatol Ther. 2017 Sep;30(5). doi: 10.1111/dth.12503. Epub 2017 May 26.
10
Accuracy of genotype MTBDR line probe assay in patients with tuberculous pleural effusion: comparison with clinical and culture based diagnosis.结核性胸腔积液患者基因型 MTBDR 线探针检测的准确性：与临床和培养为基础的诊断比较。
Infect Dis (Lond). 2020 Apr;52(4):235-241. doi: 10.1080/23744235.2019.1697462. Epub 2019 Dec 4.

本文引用的文献

1
Poor agreement between diagnostic tests for latent tuberculosis infection among HIV-infected persons in Hong Kong.香港艾滋病毒感染者中潜伏性结核感染诊断检测之间的一致性较差。
Respirology. 2016 Oct;21(7):1322-9. doi: 10.1111/resp.12805. Epub 2016 Apr 28.
2
Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.台湾接受肿瘤坏死因子阻滞剂治疗的银屑病患者中应用 QuantiFERON(®)-TB Gold 检测的临床经验。
Br J Dermatol. 2011 Mar;164(3):553-9. doi: 10.1111/j.1365-2133.2010.10137.x. Epub 2011 Feb 17.
3
Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).
抗 TNF 治疗的类风湿关节炎患者的结核药物特异性风险：来自英国风湿病学会生物制剂注册处（BSRBR）的结果。
Ann Rheum Dis. 2010 Mar;69(3):522-8. doi: 10.1136/ard.2009.118935. Epub 2009 Oct 22.